Coherus Biosciences | Lucro Operacional





Lucro Operacional Alterar Data
AbbVie USD 5.81B 1.23B 2025-12
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Akebia Therapeutics USD 13.51M 27.82M 2025-03
ALKERMES USD -10.95M 100.03M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -1.7M 8.47M 2025-09
Amgen USD 3.96B 464M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Biogen USD 659.6M 192.2M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Coherus Biosciences USD -45.43M 3.13M 2025-03
Eli Lilly USD 8.99B 599.9M 2025-12
Fujifilm JPY 89.96B 6.77B 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Merck USD 6.24B 318M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 3.99B 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Teva Pharmaceutical Industries USD 487M 581M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Xencor USD -53.63M 6.11M 2025-12
Zoetis USD 835M 101M 2025-12


Coherus Biosciences Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2026.